Cargando…

Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection

BACKGROUND: There is a lack of consensus concerning the definition of re-irradiation and re-irradiation volumes in head and neck cancer (HNC). The aim of the present study is to introduce a more strict definition of the re-irradiated volume that might better predict the risk of serious side-effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Embring, Anna, Onjukka, Eva, Mercke, Claes, Lax, Ingmar, Berglund, Anders, Bornedal, Sara, Wennberg, Berit, Friesland, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278185/
https://www.ncbi.nlm.nih.gov/pubmed/32513217
http://dx.doi.org/10.1186/s13014-020-01587-3
_version_ 1783543283083902976
author Embring, Anna
Onjukka, Eva
Mercke, Claes
Lax, Ingmar
Berglund, Anders
Bornedal, Sara
Wennberg, Berit
Friesland, Signe
author_facet Embring, Anna
Onjukka, Eva
Mercke, Claes
Lax, Ingmar
Berglund, Anders
Bornedal, Sara
Wennberg, Berit
Friesland, Signe
author_sort Embring, Anna
collection PubMed
description BACKGROUND: There is a lack of consensus concerning the definition of re-irradiation and re-irradiation volumes in head and neck cancer (HNC). The aim of the present study is to introduce a more strict definition of the re-irradiated volume that might better predict the risk of serious side-effects from treatment. METHODS: Fifty-four consecutive patients re-irradiated for HNC cancer were retrospectively analysed. CT images were deformably registered and the dose distributions accumulated after conversion to EQD2. Patients with a cumulative dose of ≥100 Gy in the overlapping volume (V100) were included in the study. Survival data and radiation-related acute and late toxicities were recorded. RESULTS: The overall survival of all included patients at 2 and 5 years was 42.6 and 27.3% respectively and the progression free survival at 2 and 5 years was 32.5 and 28.5% respectively. The overall rate of any event of severe (grade ≥ 3) acute and late toxicity was 26 and 51%, respectively. We found that severe acute toxicity was more common in patients who had a larger overlapping volume (V100 > mean) where 43% of the patients experienced grade ≥ 3 acute toxicity, compared to the patients with smaller overlapping volumes (V100 < mean) where only 11% had severe toxicity (p = 0.02). The seemingly high rates of late toxicity in the present study could be due to the use of a more strict definition of re-irradiation. In previous studies also patients with low dose overlap are included and our results imply that there is a risk that previous studies might have overestimated the risk-benefit ratio in re-irradiation of HNC. CONCLUSIONS: Our study describes the outcome of a patient material where a more strict definition of the re-irradiated volume is used. With this definition, which could better describe the volume of highest risk for serious complications, we found that larger such overlapping volumes result in an increase in severe acute side-effects. A clear definition of re-irradiation and re-irradiation volumes is of utmost importance for future studies of HNC to make results from different studies comparable.
format Online
Article
Text
id pubmed-7278185
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72781852020-06-09 Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection Embring, Anna Onjukka, Eva Mercke, Claes Lax, Ingmar Berglund, Anders Bornedal, Sara Wennberg, Berit Friesland, Signe Radiat Oncol Research BACKGROUND: There is a lack of consensus concerning the definition of re-irradiation and re-irradiation volumes in head and neck cancer (HNC). The aim of the present study is to introduce a more strict definition of the re-irradiated volume that might better predict the risk of serious side-effects from treatment. METHODS: Fifty-four consecutive patients re-irradiated for HNC cancer were retrospectively analysed. CT images were deformably registered and the dose distributions accumulated after conversion to EQD2. Patients with a cumulative dose of ≥100 Gy in the overlapping volume (V100) were included in the study. Survival data and radiation-related acute and late toxicities were recorded. RESULTS: The overall survival of all included patients at 2 and 5 years was 42.6 and 27.3% respectively and the progression free survival at 2 and 5 years was 32.5 and 28.5% respectively. The overall rate of any event of severe (grade ≥ 3) acute and late toxicity was 26 and 51%, respectively. We found that severe acute toxicity was more common in patients who had a larger overlapping volume (V100 > mean) where 43% of the patients experienced grade ≥ 3 acute toxicity, compared to the patients with smaller overlapping volumes (V100 < mean) where only 11% had severe toxicity (p = 0.02). The seemingly high rates of late toxicity in the present study could be due to the use of a more strict definition of re-irradiation. In previous studies also patients with low dose overlap are included and our results imply that there is a risk that previous studies might have overestimated the risk-benefit ratio in re-irradiation of HNC. CONCLUSIONS: Our study describes the outcome of a patient material where a more strict definition of the re-irradiated volume is used. With this definition, which could better describe the volume of highest risk for serious complications, we found that larger such overlapping volumes result in an increase in severe acute side-effects. A clear definition of re-irradiation and re-irradiation volumes is of utmost importance for future studies of HNC to make results from different studies comparable. BioMed Central 2020-06-08 /pmc/articles/PMC7278185/ /pubmed/32513217 http://dx.doi.org/10.1186/s13014-020-01587-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Embring, Anna
Onjukka, Eva
Mercke, Claes
Lax, Ingmar
Berglund, Anders
Bornedal, Sara
Wennberg, Berit
Friesland, Signe
Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
title Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
title_full Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
title_fullStr Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
title_full_unstemmed Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
title_short Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
title_sort overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278185/
https://www.ncbi.nlm.nih.gov/pubmed/32513217
http://dx.doi.org/10.1186/s13014-020-01587-3
work_keys_str_mv AT embringanna overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection
AT onjukkaeva overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection
AT merckeclaes overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection
AT laxingmar overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection
AT berglundanders overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection
AT bornedalsara overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection
AT wennbergberit overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection
AT frieslandsigne overlappingvolumesinreirradiationforheadandneckcanceranimportantfactorforpatientselection